NCT04958057

Brief Summary

Preeclampsia is a disease of pregnancy and first few weeks after birth. It is diagnosed as new onset of high blood pressure and injury to organs such as kidneys, liver, and brain. Preeclampsia is growing at a rapid rate - rate that exceeds diabetes and heart disease. Over half a million lives lost each year to preeclampsia. Women with a history of preeclampsia have 3-4 times the risk of high blood pressure. They also have double the risk for heart disease and stroke. Racial and ethnic disparities are present in preeclampsia. Black women are at higher risk of developing preeclampsia. They are also at much higher risk of dying from preeclampsia than other women. The reasons behind such disparities are unclear. What may explain these differences are social determinants of health. The contribution of social determinants to differences in preeclampsia is well recognized. However, a major gap in research remains strategies that address these factors. Our study will test a lifestyle intervention incorporating social risk factors to reduce the risk of preeclampsia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 28, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

July 12, 2021

Completed
9 months until next milestone

Study Start

First participant enrolled

March 28, 2022

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

August 7, 2025

Status Verified

August 1, 2025

Enrollment Period

2.7 years

First QC Date

June 28, 2021

Last Update Submit

August 3, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Retention

    Retention will be measured by session attendance rates.

    Post intervention measured at the completion of the last study visit, 3 years

  • Systolic and diastolic blood pressure: Post Intervention

    BP will be taken by a study trained and certified research assistant using the study OMRON automated device.

    Post intervention/at the last study visit, up to 40 weeks

  • Systolic and diastolic blood pressure: 6 Weeks Postpartum

    BP will be taken by a study trained and certified research assistant using the study OMRON automated device.

    At 6 weeks postpartum visit

Secondary Outcomes (1)

  • Preeclampsia

    At the 6 weeks postpartum visit through patient interview, confirmed with medical record review

Study Arms (2)

Routine prenatal care

NO INTERVENTION

Routine prenatal care: All women participating in the study will receive routine prenatal care by their obstetric provider, consisting of 1 prenatal visit a month up to 28 weeks of gestation, 1 prenatal visit every 2 weeks during 28-36 weeks and weekly visits during 36-40 weeks.

SAIL intervention

EXPERIMENTAL

6 monthly group sessions with the study nurse with a background in prenatal care and the PI that will include each group will include preeclampsia education, coaching on stress management, resource navigation, and training in problem solving.

Behavioral: SAIL

Interventions

SAILBEHAVIORAL

6 monthly group sessions with the study nurse with a background in prenatal care and the PI that will include each group will include preeclampsia education, coaching on stress management, resource navigation, and training in problem solving.

Also known as: SociAl rIsks-focused Lifestyle intervention
SAIL intervention

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • self-report as African-American/Non-Hispanic black
  • residence in inner-city Milwaukee
  • nulliparity
  • gestational age at enrollment \<=16 weeks
  • able and willing to give informed consent

You may not qualify if:

  • not able to communicate in English
  • major fetal anomaly
  • psychiatric illness that precludes group participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical College of Wisconsin

Wauwatosa, Wisconsin, 53226, United States

Location

MeSH Terms

Conditions

Pre-Eclampsia

Condition Hierarchy (Ancestors)

Hypertension, Pregnancy-InducedPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Group prenatal care with a focus on preeclampsia prevention
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

June 28, 2021

First Posted

July 12, 2021

Study Start

March 28, 2022

Primary Completion

November 30, 2024

Study Completion

December 31, 2024

Last Updated

August 7, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

The proposed study will be conducted, and the data analyzed, and results disseminated in an objective and transparent manner. All investigators are aware of and agree to abide by the principles for sharing research resources, as described by NIH in "Principles and Guidelines for Recipients of NIH Research Grants and Contracts on Obtaining and Disseminating Biomedical Research Programs."

Locations